Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT01818505 Recruiting - Metabolic Syndrome Clinical Trials

The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome

URIC
Start date: March 2013
Phase: N/A
Study type: Observational

Patients with hyperuricemia were confirmed to have higher risks of cardiovascular disease, but the exact mechanism remained to be elucidated. Many connective tissue diseases such as rheumatoid arthritis are often associated with antiphospholipid antibodies-associated endothelial impairment. In the present study, the investigators will analyze the presence of antiphospholipid antibodies in the serum of the patients with gout/asymptomatic hyperuricemia, with a comparison to the patients of osteoarthritis but without hyperuricemia and gout. The investigators expect to find a correlation between these pathogenic antibody and those cardiovascular co-morbidities.

NCT ID: NCT01818297 Terminated - Clinical trials for Failed Back Surgery Syndrome

Subcutaneous Nerve Stimulation for Failed Back Surgery Syndrome (FBSS) Patients

SubQStim
Start date: April 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of Subcutaneous Nerve Stimulation (SQS) (also known as Peripheral Nerve Stimulation [PNS]) in the reduction of chronic, intractable post-surgical back pain in adults.

NCT ID: NCT01817517 Suspended - Tourette Syndrome Clinical Trials

Thalamic Deep Brain Stimulation for the Treatment of Refractory Tourette Syndrome

Start date: March 2014
Phase: N/A
Study type: Interventional

This research is being performed to try to understand if the use of deep brain stimulation or DBS can treat the symptoms of Tourette syndrome that do not respond well to current medications. In order to do this the investigators will place small stimulation leads on both sides of the brain in a region (a portion of the thalamus) that may alter the abnormal activity in the brain contributing to the symptoms of Tourette syndrome. This requires two surgical procedures, and several preoperative and postoperative visits for tuning the stimulation parameters and recording stimulation effects. The FDA has not approved DBS for use in people with Tourette syndrome, and Medtronic (the manufacturer of the device) has not conducted testing for the system in Tourette syndrome. Therefore its use in this study is experimental.

NCT ID: NCT01816620 Completed - POEMS Syndrome Clinical Trials

Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome

Start date: March 2014
Phase: Phase 2
Study type: Interventional

The purpose of this prospective study is to determine the efficacy and safety of lenalidomide plus dexamethasone in patients with newly diagnosed POEMS syndrome.

NCT ID: NCT01815164 Completed - Clinical trials for Irritable Bowel Syndrome

Effect of Hypnotherapy and Educational Intervention in Irritable Bowel Syndrome

Start date: August 2007
Phase: N/A
Study type: Interventional

Aim: Gut directed hypnotherapy can reduce IBS symptoms but the mechanisms underlying this therapeutic effect remain unknown. We determined the effect of hypnotherapy and educational intervention on brain responses to cued rectal distensions in IBS patients. Methods: 44 women with moderate to severe IBS and 20 healthy controls (HCs) were included.. Blood oxygen level dependent (BOLD) signals were measured by functional Magnetic Resonance Imaging (fMRI) during expectation and delivery of high (45 mmHg) and low (15 mmHg) intensity rectal distensions. Twenty-five patients were assigned to hypnotherapy (HYP) and 16 to educational intervention (EDU). 31 patients completed the treatments and the post treatment fMRI. Results: Similar symptom reduction was achieved in both groups. HYP responders demonstrated a pre-post treatment BOLD attenuation in both anterior and posterior insula during high intensity distension, while EDU responders had a BOLD attenuation in prefrontal cortex. Pre-post differences for the low distension and for the two expectation conditions were almost exclusively seen in the HYP group. For all responders there was a significant correlation between treatment induced reduction of GI related anxiety and BOLD decrease in the anterior insula. Following treatment, the brain response to distension was similar to that observed in HCs, suggesting that the treatment had a normalizing effect on the central processing abnormality of visceral signals in IBS. Conclusions: The abnormal processing and enhanced perception of visceral stimuli in IBS can be normalized by psychological interventions. Symptom improvement in the treatment groups may be mediated by different brain mechanisms.

NCT ID: NCT01813630 Completed - Turner's Syndrome Clinical Trials

A Clinical Study to Assess the Efficacy and Safety of DA-3002

Start date: February 2013
Phase: Phase 3
Study type: Interventional

A study demonstrates the non-inferiority of DA-3002 when compared with Genotropin®.

NCT ID: NCT01812252 Completed - Clinical trials for Myelodysplastic Syndrome

Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant

ICT-HCT
Start date: August 19, 2013
Phase: Phase 2
Study type: Interventional

This randomized clinical trial studies different chemotherapies in treating patients with myelodysplastic syndrome before donor stem cell transplant. Giving chemotherapy before a donor stem cell transplant helps stop the growth of cancer cells in the bone marrow, including normal blood-forming cells (stem cells) and cancer cells, and may prevent the myelodysplastic syndrome from coming back after the transplant. When the healthy stem cells from a donor are infused into the patient they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets.

NCT ID: NCT01812161 Completed - Clinical trials for Polycystic Ovary Syndrome

Effect of Low-frequency Electroacupuncture (EA) on Polycystic Ovary Syndrome

Start date: November 2012
Phase: N/A
Study type: Interventional

Low-frequency electroacupuncture (EA) can decrease serum 17-hydroxyprogesterone (17-OHP), androstenedione (A) and testosterone (T)of young women with polycystic ovary syndrome in the Human chorionic gonadotrophin (HCG) stimulation test ,also,we hypothesize that EA is more efficiency in improving ovulation rate and menstrual cycle than sham acupuncture.

NCT ID: NCT01811654 Completed - Clinical trials for Patellofemoral Pain Syndrome

Effectiveness Trial for Evaluating IAHA for PFPS

PFPS
Start date: April 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the safety and effectiveness of intra-articular hyaluronan (IAHA) injections for the treatment of symptomatic patellofemoral pain syndrome (PFPS) and determine if this treatment can provide incremental clinical benefits over standard care for patients with this diagnosis.

NCT ID: NCT01808508 Completed - Down Syndrome Clinical Trials

Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome

TRIO
Start date: September 2010
Phase: N/A
Study type: Interventional

Many individuals with Down syndrome (DS) have breathing problems during sleep. This is called obstructive sleep apnea syndrome (OSAS). OSAS is very common in individuals with Down syndrome because of the shape of their face and tongue and because of their low muscle tone. OSAS can cause a lot of health problems including behavioral and learning problems as well as heart problems. The purpose of this research study is to look at the effects of treating OSAS in individuals with Down syndrome with a machine called Continuous Positive Airway Pressure (CPAP). The investigators want to see if treatment of OSAS improves learning, behavior and heart problems.